Business Wire

IFF Opens New Flavors Plant and Naturals Lab in China; Reinforces Commitment to Sustainability and the Region

Jaa

Regulatory News:

International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF), a leading innovator of scent, taste and nutrition, is opening two new facilities in China -- a flavors manufacturing facility in the Zhangjiagang Free Trade Zone on October 9, and a Natural Product Research lab, located in the Nanjing Life Science Park, on October 15. The flavors plant is the Company’s second in China and is designed to supplement IFF’s existing flavors and manufacturing operations in Guangzhou. The Naturals Lab is the company’s first outside of the US.

“China is a critical component of our long-term strategy,” said Andreas Fibig, IFF Chairman and CEO. “The opening of these new sites will support our efforts to be a partner of choice and to grow in this exciting region. Our presence in Zhangjiagang allows us to better serve our Chinese customers and focus on driving differentiated products within the broader Greater Asian market and beyond.” Mr. Fibig continued, “Ever-mindful of the value of naturals for consumers around the world, the output of the new Naturals Lab is not limited by region. It is an opportunity to combine our discoveries with our innovative technologies to create winning solutions for our global customers.”

The Zhangjiagang site spans 66,800 square meters, encompassing the main manufacturing building that is fitted with a strong odor control system, quality control labs and an ambient warehouse for goods. Aligned with IFF’s commitment to sustainability, this facility is designed to have zero liquid discharge by reusing all water on-site, and is built to LEED Silver qualifications. The site will initially focus on powder flavor production with additional flavor technologies coming on line in a phased approach.

“IFF is focused on creating winning tastes that resonate both locally and globally,” said Matthias Haeni, Divisional CEO,Taste. “With this new world-class facility, we are well-positioned to meet the current and future needs of our customers – and do so in a responsible and sustainable manner. We are proud to build on this legacy with our growing presence in China and look forward to being a strong corporate neighbor in our new homes within the Zhangjiagang Free Trade Zone and the Nanjing Life Science Park.”

The Natural Product Research lab is approximately 520 m2 and is equipped with state-of-the-art systems for the research and development of flavors from natural sources. The lab is strategically located to leverage the botanical supply chain, biodiversity, and accumulated botanical and phytochemical knowledge prevalent throughout China’s expansive history. The facility will expand the Company’s capabilities in natural product research and address the accelerating consumer demand for naturals and clean label. An extension of the current Natural Product Research team based in Union Beach, New Jersey, US, it is expected to accelerate IFF’s natural product pipeline.

“Speaking for the team, we cannot wait to see what innovations we will discover to help support the growing demand for naturals,” said Dr Gregory Yep, EVP Chief Global Scientific & Sustainability Officer. “IFF is committed to sustainability in all we do. We are excited to partner with our regional and global customers and help bring their products to consumers in an environmentally responsible manner. These two sites are positioned to push the boundaries of what’s possible for IFF in Greater China and around the world.”

# # #

Meet IFF

International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of scent, taste, and nutrition, with over 110 manufacturing facilities, 100 R&D centers, and 33,000 customers globally. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers experience in more than 150,000 unique products sold annually. Our 13,000 team members globally take advantage of leading consumer insights, naturals exploration, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products. Learn more at www.iff.com, Twitter , Facebook, Instagram, and LinkedIn.

Contact information

IFF
Michael DeVeau, 212-708-7164
VP, Corporate Strategy, Investor Relations & Communications
Michael.DeVeau@iff.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Airspan Introduces 5G Millimeter Wave RAN Infrastructure Utilizing the Qualcomm FSM100xx 5G Platform19.2.2019 16:36:00Tiedote

Airspan Networks Inc. is excited to announce today that they will be expanding their cooperation with Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, to include the development of 5G NR mmWave RAN solutions, leveraging the Qualcomm FSM100xx 5G Platform. This comes in the wake of the joint multi-award-winning success in 4G for the Sprint Magic Box and Reliance Jio’s ground-breaking ultra-dense Greenfield network. Airspan has deployed close to half a million small cells worldwide based on the powerful Qualcomm FSM99xx Small Cell Platform, leveraging its advanced feature sets. Airspan has been able to deliver on the promise of 4G small cells to improve indoor and outdoor wireless network capacity and coverage, increasing macro network efficiency and revolutionizing TCO. Airspan is developing 5G RAN solutions, in both Sub-6 GHz and mmWave bands to meet the wide range of challenges experienced today by mobile operators. The products will feature advanced technologies inc

Sartorius Closes Fiscal 2018 Successfully and Aims to Further Expand19.2.2019 16:08:00Tiedote

Sartorius (FWB:SRT), a leading international partner of biopharmaceutical research and the industry, confirmed its preliminary figures with the publication of its 2018 Annual Report. Accordingly, the Group continued on the growth track in both divisions and across all geographies, and thus achieved its forecast raised considerably at mid-year. Group sales revenue rose in constant currencies by 13.2% to 1,566.0 million euros (reported: +11.5%), with the non-organic share of this figure amounting to around one percentage point. The EMEA region (Europe | Middle East | Africa) accounted for 42% of consolidated sales; the Americas, 33%; and Asia | Pacific, 25%. Order intake rose in constant currencies by 12.5% to 1,662.5 million euros. The positive development of the Group is reflected by the organic increase in the number of employees. As at December 31, 2018, a total of 8,125 people were employed at Sartorius worldwide; this was a year-over-year gain of some 600 new employees or 8.3%. “Sa

BOC Group Announces the Release of its Latest BPM Suite: ADONIS NP 6.0 Out Now and Better Than Ever Before!19.2.2019 16:00:00Tiedote

BOC Group has just released the next major version upgrade of its BPM suite ADONIS NP and introduced a great mix of brand new features, enhanced extensions and different technology updates. The new ADONIS NP 6.0 brings meaningful innovation for all users, with a special emphasis on making better decisions faster with the help of Business Process Simulation & Optimization. Providing powerful Process Simulation, the latest release of the Business Transformation Suite ADONIS NP encompasses major new features and cutting-edge capabilities to facilitate, optimize and accelerate digital transformation! It is a step forward into a new era of innovation and simplicity. Tobias Rausch, ADONIS NP product manager says: “Business Process Simulation & Optimization is without a doubt the flagship feature of the new ADONIS NP 6.0. It allows you to visualize, change, slice and dice your processes and test alternatives in a risk-free environment, before taking an actual step change and committing capita

The Company SP3H Announces It Has Entered the Final Phase of Its European VIP Program (Intelligent and Clean Vehicle), Linked to the Pre-Industrialization of Its fluidBOX Infrared Scanners19.2.2019 14:05:00Tiedote

The first orders have already been posted on the car market, in anticipation of the introduction of the new EU legislation on CO 2 emissions target from vehicles in 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190219005456/en/ This success has enabled SP3H to receive the second tranche of € 473k from the EU, thus raising the amount received since October 2017 to € 1M. During the summer of 2017, VIP received the prestigious H2020 label "EIC SME Instrument Phase 2" in the "transport & smart cities mobility" category. With a total budget of 1.7M €, VIP is subsidized by the European Union for 70% or 1.2M€ has enabled SP3H to join the prestigious circle of French winners of the H2020 EIC SME Instrument Phase 1 and 2 programs. VIP is the pre-industrialization program for Fluidbox sensors, the first miniaturized scanner in the world capable of analyzing the quality of fuels in vehicles. The heart of the program remains clos

Axonics® Announces Positive Top-Line Clinical Data from its ARTISAN-SNM Pivotal Study19.2.2019 14:00:00Tiedote

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, disclosed today positive top-line results from the ARTISAN-SNM pivotal study, designed to gain marketing approval from the U.S. Food & Drug Administration (“FDA”) for the Axonics r-SNM® System1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190219005354/en/ Figure 1A & 1B The clinical study demonstrated that patients implanted with the Axonics r-SNM System received clinically meaningful and statistically significant improvements in Urinary Urgency Incontinence (“UUI”) symptoms and quality of life. Additionally, the study met all secondary endpoints. No serious device-related adverse events have been reported. The ARTISAN-SNM study is a 129-patient single-arm, prospective, multi-center,

H.I.G. Capital Closes H.I.G. Europe Real Estate Fund Well Above Target19.2.2019 14:00:00Tiedote

H.I.G. Capital (“H.I.G.”), a leading global alternative asset management firm with over $30 billion of equity capital under management, is pleased to announce the closing of H.I.G. Europe Realty Partners II (the “Fund”). The Fund closed with aggregate capital commitments of €673 million* ($760 million), well above its target. The Fund will principally make value-add investments in the small and mid-cap real estate sector in Europe. Sami Mnaymneh and Tony Tamer, Co-CEOs of H.I.G., commented: “We are delighted with the success of H.I.G. Europe Realty Partners II. The Fund will continue to build on our local, on the ground pan-European presence and is already 16% committed. We continue to find compelling opportunities to invest in the region.” Riccardo Dallolio, Managing Director and Head of H.I.G. Europe Realty Partners, commented: “This closing validates H.I.G. Europe Realty's differentiated strategy. The Fund will invest in Europe across the capital structure and asset classes with a p

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme